Evidence map›Paper›PMID 38932502›Full record

ArticleAmyotrophic lateral sclerosis & frontotemporal degeneration2024

Automated speech analytics in ALS: higher sensitivity of digital articulatory precision over the ALSFRS-R.

Gabriela Stegmann, Chelsea Krantsevich, Julie Liss, Sherman Charles, Meredith Bartlett, Jeremy Shefner, Seward Rutkove, Kan Kawabata, Tanya Talkar, Visar Berisha

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Amyotrophic lateral sclerosis & frontotemporal degeneration, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Gabriela StegmannArizona State University, Phoenix, AZ, USA.
Chelsea KrantsevichArizona State University, Phoenix, AZ, USA.
Julie LissArizona State University, Phoenix, AZ, USA.
Sherman CharlesAural Analytics, Scottsdale, AZ, USA.
Meredith BartlettAural Analytics, Scottsdale, AZ, USA.
Jeremy ShefnerBarrow Neurological Institute, Phoenix, AZ, USA, and.
Seward RutkoveBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Kan KawabataAural Analytics, Scottsdale, AZ, USA.
Tanya TalkarAural Analytics, Scottsdale, AZ, USA.
Visar BerishaArizona State University, Phoenix, AZ, USA.

Funding

Perception of dysarthric speech: An objective model of dysarthric speech evaluation with actionable outcomesR01DC006859 · NIDCD · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI BERISHA, VISAR, LISS, JULIE M · 2004 to 2021
$4.8M
Automated objective outcome measures for clinical use in dysarthriaR43DC017625 · NIDCD · AURAL ANALYTICS, INC. · PI SCHMITT, HARRY ADAM · 2019 to 2019
$225k
National Science Foundation 1853247NIDCD NIH HHS R01 DC006859NIDCD NIH HHS R43 DC017625
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Amyotrophic Lateral SclerosisAdultAgedAlgorithmsDisease ProgressionFemaleHumansMaleMiddle AgedSeverity of Illness IndexSpeechSpeech DisordersSpeech Production MeasurementALSdigital measuresdisease progressionSpeech analyticsvalidation

Identifiers

PMID38932502
PMCPMC11496019

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.